As of May 2018, the revised “C” grade recommendation of the USPSTF for PSA screening states, “for men aged between 55–69 years the decision to undergo periodic PSA based screening for prostate cancer should be an individualized one. The gene discussed is KLK3; the disease is Familial prostate cancer.